Table 1.
Characteristics of the patients and D. fragilis episodes, coinfection and treatment.
| n (%) | |
|---|---|
| Individuals characteristics (n = 586) | |
| Gender: Female | 308 (52.6%) |
| Age (year) | 12 (IQR:6; 46) |
| Episodes >1 | 152 (25.9%) |
| Coinfection (episodes n = 739) | |
| Blastocystis hominis | 248 (33,6%) |
| Giardia Lamblia | 31 (4.2%) |
| Enterobius vermicularis | 4 (0.5%) |
| Treatment (episodes n = 739) | |
| Metronidazole | 483 (65.4%) |
| Paromomycin | 129 (17.5%) |
| Others | 61 (8.3%) |
| Non-treatment | 66 (8.9%) |
| Persistence (episodes n = 739) | 250 (33.8%) |
IQR: interquartile range.